Expedition Therapeutics raises $165 million in oversubscribed Series A financing to advance EXPD-101 for COPD. The round was co-led by Sofinnova Investments and Novo Holdings.
Amount Raised
$165 Million
Round Type
Series A
San FranciscoBiotechnologyHealth CareresearchInvestors
Description
Expedition Therapeutics, a biotech company developing therapies for inflammatory and respiratory diseases, announced the closing of a $165 million Series A financing. The round was co-led by Sofinnova Investments and Novo Holdings, with additional investments from multiple investors. Proceeds will advance Expedition’s lead candidate, EXPD-101, through a global Phase 2 study in COPD. This financing allows for accelerated development and potential treatment of a broad range of COPD patients.
Quick answer
Expedition Therapeutics raised $165 Million in a Series A round, dated October 9, 2025. Investors: Venrock Healthcare Capital Partners, BVF Partners, Forbion, Dawn Biopharma, Adage, Balyasny, Logos Capital and Sanofi Ventures. Expedition Therapeutics is based in San Francisco, California, United States.
- How much did Expedition Therapeutics raise?
- Expedition Therapeutics raised $165 Million in a Series A round on October 9, 2025.
- Who invested in Expedition Therapeutics?
- Venrock Healthcare Capital Partners, BVF Partners, Forbion, Dawn Biopharma, Adage, Balyasny, Logos Capital and Sanofi Ventures are named as investors in this round.
- What does Expedition Therapeutics do?
- Expedition Therapeutics is a biotechnology company developing novel therapies for serious inflammatory and respiratory diseases.
- Where is Expedition Therapeutics based and how big is it?
- Expedition Therapeutics is based in San Francisco, California, United States. Fundz records about 6 employees.
- Who are the decision-makers at Expedition Therapeutics?
- Fundz holds 2 contacts at Expedition Therapeutics, including the Chief Business Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in research and Biotechnology around the same time
Companies in the same sectors as Expedition Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Brainstorm Cell Therapeutics raised $155K (Convertible Note) on November 6, 2025.
- Hepta raised $6.7M (Seed) on November 5, 2025.
- AAVantgarde Bio raised $141M (Series B) on November 3, 2025.
- Grail raised $325M (Post-IPO Equity) on October 20, 2025.
- Cyclana Bio raised $6.7M (Pre-Seed) on October 20, 2025.
- Faeth Therapeutics raised $25M (Funding Round) on October 20, 2025.
Who to call at Expedition Therapeutics, and when
A new round usually means Expedition Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Expedition Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Expedition Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Expedition Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Expedition Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansExpedition Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.